FATE THERAPEUTICS INC (FATE) Stock Cash Flow
NASDAQ:FATE - Nasdaq - US31189P1021 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -186.26M | -160.93M | -281.72M | -212.15M | -173.39M | |||
| Depreciation Amortization | 18.96M | 18.28M | 13.76M | 5.85M | 3.09M | |||
| Change In Working Capital | -1.96M | 19.18M | -34.71M | 2.10M | -12.77M | |||
| Interest Paid | N/A | N/A | N/A | 0.00 | 0.00 | |||
| Other non cash items | 46.38M | -8.80M | 54.47M | 41.33M | 143.84M | |||
| OPERATING CASH FLOW | -122.87M | -132.26M | -248.21M | -162.87M | -39.23M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -730.00K | -6.15M | -35.57M | -50.70M | -4.93M | |||
| Other Investing Activity | 12.95M | 118.82M | 202.32M | -273.32M | -156.14M | |||
| INVESTING CASH FLOW | 12.22M | 112.67M | 166.75M | -324.02M | -161.08M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 5.07M | N/A | N/A | 0.00 | N/A | |||
| Stock Issued/Repurchased | 94.82M | 85.00K | 9.21M | 453.13M | 282.35M | |||
| Other Financing Activity | N/A | N/A | 0.00 | 0.00 | 490.00K | |||
| FINANCING CASH FLOW | 99.89M | 85.00K | 9.21M | 453.13M | 282.84M | |||
| CHANGE IN CASH | -10.76M | -19.51M | -72.25M | -33.76M | 82.53M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -122.87M | -132.26M | -248.21M | -162.87M | -39.23M | |||
| Capital Expenditure | -730.00K | -6.15M | -35.57M | -50.70M | -4.93M | |||
| FREE CASH FLOW | -123.60M | -138.42M | -283.78M | -213.57M | -44.16M | |||
All data in USD